A detailed history of Bard Financial Services, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Bard Financial Services, Inc. holds 30,755 shares of MDT stock, worth $2.72 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
30,755
Previous 38,755 20.64%
Holding current value
$2.72 Million
Previous $3.49 Million 29.61%
% of portfolio
0.3%
Previous 0.42%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

SELL
$79.61 - $92.24 $636,880 - $737,920
-8,000 Reduced 20.64%
30,755 $2.46 Million
Q3 2024

Nov 20, 2024

BUY
$76.84 - $91.03 $699,628 - $828,828
9,105 Added 30.71%
38,755 $3.49 Million
Q3 2024

Oct 04, 2024

SELL
$76.84 - $91.03 $953,200 - $1.13 Million
-12,405 Reduced 29.5%
29,650 $2.67 Million
Q2 2024

Jul 09, 2024

BUY
$78.71 - $87.02 $28,729 - $31,762
365 Added 0.88%
42,055 $3.31 Million
Q1 2024

May 06, 2024

SELL
$82.84 - $88.09 $22,366 - $23,784
-270 Reduced 0.64%
41,690 $3.63 Million
Q4 2023

Feb 09, 2024

BUY
$69.43 - $83.43 $658,890 - $791,750
9,490 Added 29.23%
41,960 $3.46 Million
Q3 2023

Oct 16, 2023

SELL
$78.22 - $90.4 $107,552 - $124,300
-1,375 Reduced 4.06%
32,470 $2.54 Million
Q2 2023

Jul 11, 2023

BUY
$79.47 - $91.38 $39,735 - $45,690
500 Added 1.5%
33,845 $2.98 Million
Q1 2023

Apr 26, 2023

BUY
$76.72 - $87.58 $688,178 - $785,592
8,970 Added 36.8%
33,345 $2.69 Million
Q4 2022

Jan 25, 2023

BUY
$76.18 - $87.74 $1.41 Million - $1.63 Million
18,535 Added 317.38%
24,375 $1.89 Million
Q3 2022

Oct 26, 2022

BUY
$80.75 - $95.31 $125,162 - $147,730
1,550 Added 36.13%
5,840 $472,000
Q4 2020

Mar 26, 2021

BUY
$100.57 - $117.14 $431,445 - $502,530
4,290 New
4,290 $503,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.